1Sokal EM, Smets F. Hepatocyte transplantation in a 4 - year - old girl with peroxisomal biogenesis disease: t~hnique, safety, and metabolic follow - up. Transpl,2003,76(4): 735 - 738
2Selden C, Casbard A. Characterization of long- term survival of syngeneic hepatocytes in rat peritoneum. Cell Transpl, 2003, 12(6):569-578
3Liu ZC, Chang TM. Coencapsulation of hepatocytes and bone marrow stem cells: in vitro conversion of ammonia and in vivo lowering of bilirubin in hyperbilirubemia Gunn rats. Int J Artif Organs,2003,26(6): 491 - 497
4Bumgardner GL, Li J, Heininger M, et al. in vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transpl, 1998,65:47 - 52
5Hoshino K, Nashan B, Steinhoff G, et al. Expression of cell - matrix molecules and integrin receptors in human liver grafts during chronic rejection. Transpl Int, 1994,7 Suppl 1 :S637 - 640
6Krams SM, Fox CK, Beatty PR, et al. Human hepatocytes produce an isoform of FAS that inhibits apoptosis. Transpl, 1998,65(5) :713 - 721
7Wesolowska A, Olszewski WL. Transplantation of hepatocytes: elimination of recipient natural killer cells with irradiation and bone marrow reconstitution prevent early graft dysfunction. Transpl Proc, 2003,35 (6):2358 - 2360
8Fujisawa K, Saito S. Suppression of allogeneic response by viral IL - 10 gene transfer. Cell Transpl, 2003,12(4) :379 - 387
